<SEC-DOCUMENT>0001615774-18-005685.txt : 20180626
<SEC-HEADER>0001615774-18-005685.hdr.sgml : 20180626
<ACCEPTANCE-DATETIME>20180626062613
ACCESSION NUMBER:		0001615774-18-005685
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20180626
FILED AS OF DATE:		20180626
DATE AS OF CHANGE:		20180626

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immuron Ltd
		CENTRAL INDEX KEY:			0001660046
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38104
		FILM NUMBER:		18918227

	BUSINESS ADDRESS:	
		STREET 1:		62 LYGON STREET
		STREET 2:		LEVEL 3
		CITY:			CARLTON, VICTORIA
		STATE:			C3
		ZIP:			3053
		BUSINESS PHONE:		61 03 9824 5254

	MAIL ADDRESS:	
		STREET 1:		62 LYGON STREET
		STREET 2:		LEVEL 3
		CITY:			CARLTON, VICTORIA
		STATE:			C3
		ZIP:			3053
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>s111003_6k.htm
<DESCRIPTION>FORM 6K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B>Form 6-K</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">For the Month of June 2018</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">Commission File Number: 001-38104</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B><U>IMMURON LIMITED</U></B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">(Name of Registrant)</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B><U>Level 3, 62 Lygon Street, Carlton South,
Victoria, 3053, Australia</U></B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">Form 20-F <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9746;
</FONT>&nbsp;Form 40-F <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Calibri,sans-serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">Yes <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
<FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9746;&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri,sans-serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">If &ldquo;Yes&rdquo; is marked, indicate below the file number assigned
to the registrant in connection with Rule 12g3-2(b): 82-&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B>IMMURON LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B><U>EXPLANATORY NOTE</U></B></P>

<P STYLE="font: 10pt Arial,sans-serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">Immuron Limited (the &ldquo;Company&rdquo;) published two announcements
(the &ldquo;Public Notices&rdquo;) to the Australian Securities Exchange on June 26, 2018 titled:</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">-</TD><TD>&ldquo;Immuron Announces Board Appointment&rdquo;; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman,serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">-</TD><TD>&ldquo;Appendix 3X &ndash; Initial Director&rsquo;s Interest Notice (RB)&rdquo;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman,serif"></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">A copy of the Public Notice is attached as an
exhibit to this report on Form 6-K.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">This report on Form 6-K (including the exhibit
hereto) shall not be deemed to be &ldquo;filed&rdquo; for purposes of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as
shall be expressly set forth by specific reference in such filing.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B>EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; border-bottom: black 1pt solid; padding-right: 5.4pt; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="width: 91%; border-bottom: black 1pt solid; padding-right: 5.4pt; font-family: Times New Roman,serif"><BR>
<FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; font-family: Times New Roman,serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif; text-align: center"><A HREF="s111003_ex99-1.htm"><FONT STYLE="font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt">
        <P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><A HREF="s111003_ex99-1.htm">Immuron Announces Board Appointment</A></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif; text-align: center"><A HREF="s111003_ex99-2.htm"><FONT STYLE="font-size: 10pt">99.2</FONT></A></TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; font-family: Times New Roman,serif"><A HREF="s111003_ex99-2.htm"><FONT STYLE="font-size: 10pt">Appendix 3X &ndash; Initial Director&rsquo;s Interest Notice (RB)</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><B>IMMURON LIMITED</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman,serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman,serif"><IMG SRC="img001_v1.jpg" ALT=""></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Date:&nbsp;&nbsp;June 26, 2018</FONT></TD>
    <TD STYLE="width: 2%; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: black 1pt solid; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">/s/ Peter Vaughan</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Peter Vaughan</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Joint Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>s111003_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="img002_v1.jpg" ALT="(IMMURON LOGO)"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Immuron
Announces Board Appointment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Melbourne,
Australia, 26 June 2018: </B><FONT STYLE="color: black">Australian biopharmaceutical company Immuron Limited (ASX: IMC), is pleased
to announce the appointment of New York based Mr. Richard Jay Berman to serve as a Director of the Company effective from 1 July
2018.</FONT></FONT></P>

<P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: black">&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
Berman&rsquo;s business career spans over 35 years of venture capital, senior management and merger &amp; acquisitions experience. Mr.
Berman is a well-respected and seasoned professional, senior executive and public company Board member with extensive experience
in many business sectors including finance, technology, retail, bio-science and real estate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Berman is a director of three public healthcare companies: Advaxis, Inc., Catasys, Inc., and Cryoport Inc. He has also served
as a director or officer of more than a dozen public and private companies. In 2016, he joined the advisory Board of Medifirst
while in 2014, he was elected Chairman of MetaStat Inc. From 2006-2011, he was Chairman of National Investment Managers, a company
with $12 billion in pension administration assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">From
2002 to 2010, he was a director of Nexmed Inc where he also served as Chairman/CEO in 2008 and 2009 (now called Apricus Biosciences,
Inc.). From 1998-2000, he was employed by Internet Commerce Corporation (now Easylink Services) as Chairman and CEO, and was a
director from 1998 to 2012.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously,
Mr. Berman worked at Goldman Sachs; was Senior Vice President of Bankers Trust Company, where he started the M&amp;A and Leveraged
Buyout Departments; created the largest battery company in the world in the 1980&rsquo;s by merging Prestolite, General Battery and
Exide to form Exide Technologies (XIDE); helped to create what is now Soho (NYC) by developing five buildings; and advised on
over $4 billion of M&amp;A transactions in over 300 deals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">He
is a past Director of the Stern School of Business of NYU where he obtained his BS and MBA. He also has US and foreign law degrees
from Boston College and The Hague Academy of International Law, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to shareholder approval, the Company agrees to issue 2 million unlisted options exercisable at A$0.50 per option on or before
30 June 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
press release is being made pursuant to, and in accordance with, Rule 155 under the U.S. Securities Act of 1933, as amended, and
does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation
or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of that jurisdiction.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt 0in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
- - END - - -</FONT></P>

<P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt 0in; text-align: center">&nbsp;</P>

<P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt 0in; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="img003_v1.jpg" ALT=""></FONT></P>

<P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt 0in; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt 0in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt 0in; text-align: right"><IMG SRC="img004_v1.jpg" ALT=""></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt 0in; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 31%; padding-right: 5.4pt; font: 10pt Times New Roman, Times, Serif"><P STYLE="color: #0070C0; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>COMPANY
        CONTACT:</U></B></FONT></P>
        <P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
        <P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Jerry
        Kanellos</B></FONT></P>
        <P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
        Executive Officer (Interim)</FONT></P>
        <P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ph:
        +61 (0)3 9824 5254</FONT></P>
        <P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">jerrykanellos@immuron.com&nbsp;</FONT></P></TD>
    <TD STYLE="width: 36%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0079C1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>USA
        INVESTOR RELATIONS:</U></B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Jon
        Cunningham</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RedChip
        Companies, Inc.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
        Ph: +1 (407) 644 4256, (ext. 107)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">jon@redchip.com</FONT></P></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0079C1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AUS
        INVESTOR RELATIONS:</U></B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Peter
        Taylor</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NWR
        Communications</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ph:
        +61 (0)412 036 231</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">peter@nwrcommunications.com.au</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ABOUT
IMMURON:</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immuron
Limited (ASX: IMC, NASDAQ: IMRN), is an Australian microbiome biopharmaceutical company focused on developing and commercializing
orally delivered targeted polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases.. Immuron has
a unique and safe technology platform that enables a shorter development therapeutic cycle. The Company currently markets and
sells Travelan<SUP>&reg;</SUP> for the prevention of Travelers&rsquo; Diarrhea and its lead clinical candidate, IMM-124E, is in
Phase II clinical trials for <B>Non-Alcoholic Steatohepatitis</B> (NASH), <B>Severe Alcoholic Hepatitis</B> (SAH) and Pediatric
<B>Nonalcoholic Fatty Liver Disease</B> (NAFLD). Immuron&rsquo;s second clinical stage asset, IMM-529, is targeting <B>Clostridium
<I>difficile </I>Infections</B> (CDI). These products together with the Company&rsquo;s other preclinical immunotherapy pipeline
products targeting immune-related diseases currently under development, will meet a large unmet need in the global immunotherapy
market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information visit: <U>http://www.immuron.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORWARD-LOOKING
STATEMENTS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release may contain &ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Such statements include, but are not limited to,
any statements relating to our growth strategy and product development programs and any other statements that are not historical
facts. Forward-looking statements are based on management&rsquo;s current expectations and are subject to risks and uncertainties
that could negatively affect our business, operating results, financial condition and stock value. Factors that could cause actual
results to differ materially from those currently anticipated include: risks relating to our growth strategy; our ability to obtain,
perform under and maintain financing and strategic agreements and relationships; risks relating to the results of research and
development activities; risks relating to the timing of starting and completing clinical trials; uncertainties relating to preclinical
and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate and retain key personnel; the
early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual
property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking
to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations
or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><IMG SRC="img003_v1.jpg" ALT="">&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>s111003_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; margin-left: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appendix
3X</B></FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Initial Director&rsquo;s Interest Notice</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; margin-left: 0"></P>

<P STYLE="font: 10pt ClassGarmnd BT,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: right; text-indent: -42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rule
3.19A.1</I></FONT></P>

<P STYLE="font: 10pt ClassGarmnd BT,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: right; text-indent: -42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 24pt Zurich Cn BT,sans-serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: center; text-indent: -42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appendix
3X</FONT></P>

<P STYLE="font: bold 24pt Zurich Cn BT,sans-serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: center; text-indent: -42.55pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 24pt Zurich Cn BT,sans-serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: center; text-indent: -42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Initial
Director&rsquo;s Interest Notice&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: justify; text-indent: -42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt ClassGarmnd BT,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX&rsquo;s
property and may be made public.</FONT></P>

<P STYLE="font: italic 10pt ClassGarmnd BT,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Century Schoolbook,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: justify; text-indent: -42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Introduced
30/9/2001.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 22%; border: Black 1pt solid; font: 10pt Times New Roman,serif; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
of Entity</B></FONT></TD>
    <TD STYLE="width: 78%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman,serif; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Immuron
    Limited</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman,serif; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABN</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman,serif; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;80
    063 114 045<B></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: justify; text-indent: -42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt ClassGarmnd BT,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
(the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section
205G of the Corporations Act.</FONT></P>

<P STYLE="font: 10pt ClassGarmnd BT,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: justify; text-indent: -42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 22%; border: Black 1pt solid; padding: 3pt 5.4pt 10pt; font-weight: bold; text-align: justify; font-family: Helvetica,sans-serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Director</FONT></TD>
    <TD STYLE="width: 78%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt 10pt; text-align: justify; font-family: Times New Roman,serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    Jay Berman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt 10pt; text-align: justify; font-family: Times New Roman,serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
    of Appointment</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt 10pt; text-align: justify; font-family: Times New Roman,serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    July 2018</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: left; text-indent: -42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Zurich Cn BT,sans-serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Part
1 - Director&rsquo;s relevant interests in securities of which the director is the registered holder</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt ClassGarmnd BT,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>In
the case of a trust, this includes interests in the trust made available by the responsible entity of the trust&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt ClassGarmnd BT,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:
In the case of a company, interests which come within paragraph (i) of the definition of &ldquo;notifiable interest of a director&rdquo;
should be disclosed in this part.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 100%; border: Black 1pt solid; font: bold 10pt Helvetica,sans-serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    &amp; class of securities</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Tahoma,sans-serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>
        <P STYLE="font: 10pt Tahoma,sans-serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000*
unlisted options exercisable at A$0.50 per option on or before 30 June 2020</FONT></P>
        <P STYLE="font: 10pt Tahoma,sans-serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Tahoma,sans-serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&nbsp;&nbsp;&nbsp;&nbsp;issuance
of these securities is subject to receipt of shareholder approval at the Company&rsquo;s next shareholder meeting.&nbsp;</FONT></P>
        <P STYLE="font: 10pt Tahoma,sans-serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: left; text-indent: -42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -42.55pt"></P><!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: -42.55pt">+ See chapter 19 for defined terms.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">11/3/2002</FONT></TD><TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">Appendix 3X&nbsp;&nbsp;Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 42.55pt; text-align: left; text-indent: -42.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">Appendix
3X</P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">Initial
Director&rsquo;s Interest Notice</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"></P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Part 2 &ndash; Director&rsquo;s relevant interests in securities
of which the director is not the registered holder</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><I>In the
case of a trust, this includes interests in the trust made available by the responsible entity of the trust</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; border: Black 1pt solid; padding: 3pt 5.4pt">
        <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of holder &amp; nature of interest</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Note: Provide details
        of the circumstances giving rise to the relevant interest.</P>
</TD>
    <TD STYLE="width: 55%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; font-weight: bold; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number &amp; class of Securities</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">Nil</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">Nil</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"><B>Part
3 &ndash; Director&rsquo;s interests in contracts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Note: In the case of a company,
interests which come within paragraph (ii) of the definition of &ldquo;notifiable interest of a director&rdquo; should be disclosed
in this part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; border: Black 1pt solid; padding-right: 5.4pt; text-align: justify; font-size: 10pt; padding-left: 5.4pt; padding-top: 3pt"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Detail of contract</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P></TD>
    <TD STYLE="width: 55%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; padding-top: 3pt"><P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">N/A</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; padding-top: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Nature of
interest</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; padding-top: 3pt"><P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">N/A</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; padding-top: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Name of registered
        holder</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>(if issued
securities)</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; padding-top: 3pt"><P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">N/A</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; padding-top: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>No. and class
of securities to which interest relates</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; padding-top: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">N/A</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; border-top: Black 1pt solid; text-align: justify">+ See chapter 19 for defined terms.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: normal 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">Appendix 3X Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 50%; text-align: right">11/3/2002</TD></TR></TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.9pt 0pt 42.55pt; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.9pt 0pt 42.55pt; text-align: justify"></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img001_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img001_v1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ - "( P$1  (1 0,1 ?_$ 'L   ,  P$! 0
M       %!@,$!P(( 0$!                     !   0,# @0#! 8'"0
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'#0&@-!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img002_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img002_v1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 2@$, P$1  (1 0,1 ?_$ +4   (" P$!
M       '!@@"! 4# 0$  @,! 0                4#! 8" 1   0,# @($
M"0<'" D%     0(#!  1!1(&(0<Q01,(46%Q@2(RLQ1TD:&Q<K(V-T)28G,T
M%77!@B/#)&0E)O"2,T.CQ#46%U-CAB='$0 " 0,!!0<"!0,% 0       0(1
M P0%(3%Q$C-!46&!(C(3P8*10G(C%+%2%?!B0S1$)/_:  P# 0 "$0,1 #\
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M+<&0R!QVQH/9,E10U+>;[:2Z?"VSQ2F_4"%'R5;M:?%*LV75$Y4?<O>G; R
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M7N#4^GY,E-1;JF0:AC1<')*C0H^66U6-S[NC8Z43[FA*GY02;$MM_D@]6I1
MIKEWW;MMK>*\2RKEQ)[BSK&V-NL0O<6L9%3$TZ>Q[)!21X[CCYZS;O3;K5U-
M&K,$J45"N?.+9L+;.YTC')[.!.;]X99O?LU:BE:!?JN+CRUH,#(=R&W>C/YU
MA6Y[-S'URVR[^7V/B9LA16^6>S=6>E2FE%NY\9TWI)EVU"ZTAYB7'.VFQ <W
M?Q.ROZQCV+=/,'HKS$>=UGY%H(W[.U]1/T5FWO-&MQZ5X>E<N\&/\\,? M>T
M<K0:7TO,0:IU/(=VP/N3@O@6/9BDV3U)<6.,;IQX%6]W G=F8 XDS9%@/UJJ
MTMCIQX(S=_WRXLL'R[Y4X+!8J/(R,1N7F7D!Q]QY(6&BH7T-I5P&GH)Z32+*
MS93DTG2(]Q<*,(IM5D*[O,[BR,_.8?EWA$&SQ;>D1FAI[1]Y>AAL@<+)];S@
M]538$$D[DAC!)#1Y8\JMM\O<$'EI:<R_9]ID\LX!<6%UI;4KU&T_/TFJE_(E
M=E3L[$<REVLC&Z.\,U'EKC;>A(DM-FQF22H)7;\QM)2;>,GS5>LZ755FZ">]
MJE'2"J>KF%P'.O9<B1-@MX_<$):F8\]OB4.!(6GTO64VJ]E)/1U5#<4L6Y1.
ML67L/*^6-:4.WRBW1FI6P'&<HRM_.;;?=QF19O=U9BVM:_K+[,CZQ'CJ#(MQ
M^39NEM+-QT543_'9"'D8+$Z&Z'HLA <:<3T%)_TXU6E%Q='O.8R4E5;BO_/[
M<LB;N=&$0NT/&H25(!X%YU.HJ/D20!YZ>Z992AS=K$>IW6Y\O8B=\J^5>&QF
M%C93*Q42\O+0EZSR0M+"%BZ4I2;C5;I-4LW-E*3C%TBB[A848Q4I*LF2_/[&
MVMG8:XL['L^D+(?;0E#J#X4K2+_R54M9,X.J9:NXT)JC16Z7'R?+[?VA"RIW
M&OI6VL< ZPJQX_7;58UH8N-^UQ,_)2L7>!:?W^-^[OWAJ_LW8^\:_P#V].N_
MR5F>5UIVFEYE2O8(;O&?>?&_!?UJZ=Z5['Q$FJ^]<!L\K_P_P?PR?I-*\SJR
MXC3#Z4>!7[FK^)67_7M^S13W"Z*$6;UF6EC?LS7U$_16:>\TJW$:YI?A]G/A
MS]H58P^K'B5\SI2X"@[O _SA,/@A+]HBFVJ=-<15I?4? L12 ?""[QP_Q_$G
M^Z*]H:>:5['Q$>J^]<!H\J#_ /7F$_4J]HJEN;UI#+"Z,1#<Y#?F1EO$ID?\
M%%.\#HH29_699Z!^PQOU2/LBLY+>S1QW(XO,1 7L7/ \?[$\?D034V+U8\2+
M*Z4N D^[X/\ /#Q\$)W[:*<:ITO,3Z9U/(L;6?'XAN\@/\8PQ_N[OVQ3S2?;
M+B)-5]T> P.2AORYQOUGQ_QE50U#K,O:?T4)3F]PYFY6_P">Q[!NG&#T5YBC
M.ZS\BT$4WC-'PH3]%9M[S1K<>E>'I7+O"??ACX%KVCE:#2^EYB#5.IY#OV"+
M;)P0_N+'LQ2;)ZDN+'&-TX\"M[D=,GFF8ZA=+N9T*'B,FQK0ITL5_P!OT,^U
M6_3_ '?4M=67-.(-_%)=[V*'):=24PDRH@/1=$7LP1Y%!5,E+_YMG>=]A/\
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M&+F2Y42+*;>DPE!$ME"KJ;4;V"AU=%=RMR23:V,XC<BVTGM1M!IL*U! "O"
M+UQ4[H:L'-8J>J2F%*;D*AK+4H-J![-:;W2KP$6KN5N4:56\XC<C*M'N//$;
MAP>9#IQ4YF:&" ]V*@K257M>WAM7MRU*'N5#R%V,_:ZF^I24I*E$)2D743T
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M-$L)QGN:9OUP=A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MQ3V,A!$I8(5*<4IUT@](UK)M?Q5#>R9W-DGL)[6-"WMBMI(*KDX4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
* 4 % !0 4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img003_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img003_v1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 2P-2 P$1  (1 0,1 ?_$ /<  0 !! ,! 0$
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M^24] :"XGS 8E>,]13TL9FJ7LCA'2YS@T#SDD *#+LW3[<[(%4ER9GQ^T61
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M=R)YA>RS%5KVK>%\[B<>Q$)?,.G<%HG0?.Y>1GX18YDT95A"0S)_,_5ZQR&
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M6*+,V:6.JWSXB*)SG!C(VDM&.!!<3@<!B&@=1Q6+N.=G47YQ>]_<$KG:8F[
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M'/(U*R%))1;3IEE%=.;I#J'T]W%KI6Z#W 8 G!:'NVX[1 +NW0OP#O7FU'W
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MJVGNXC $< F?9PQ$T NO%T^2+.((:<HZE&8X@T]U9\62\X3G"&U7)WFIIO\
M86NFS[D:G&,]YM3?/5P?.*T'N\7:G':]\W$8>3X>?AOVW5_[P^5UK:0\L.8L
M_P E9+H?\/*/:T+3S\W.5U-\MF"T#_%0GV.*LN0\P?9/% 87NYC%"?#KKT=Q
MI.AY.?D:IK"/R5M(N2_-:;Y.P7+TQ$>W!:>;GUR:I\>]S):M'9,UWQ<58\AY
MI>P&.U!3<U83@X<G1LDYYX8?=T,.8@_&MI#R YPSG!MBJV^^,;?:]:F?Q)\C
MX!B<Q43O>"5WLC*LJ0\W[8!'@8PYO1>@&O\ DZU[G=B;3\4"18".M;B'PS\Y
M9M/U3L>^G@']8M'4>+'D33X@WG;(^YIZAW]6K!DO.[V!1_$"=\WQ)"74/_EV
M.KA.!M/Q3.DVA1 ??6SA\*W."3W=+1Q^^JHOL$K3S>,?D?$<&5=?(>&CF]K@
MT*QG_GR[(&P"+1+*TAIKH!+-;-!$0Y@T>3*.FOMK;0^$?FC)\K+:X_/4$^QA
M6GJ/&MRAA^1BO$OFI@/C2!6'*_:"-JC0!^K,<9<E3!KH!D[/CP-IZA7N100^
M4 K;0^#O/;_E[E:6>9\KO9$M)/XYN7;!_9K3>Y/.R%GMF*CR0^T287()@C,!
MW^KI]$TA=MJ-@'U"8K+ZP,4/C6W@\&M^/Z5?:!GO89G>T-6EJ?';EUH_LF7;
MD_W\T#/87*Q)3[1; D WU-MQ%8W+P#)Y+%N'LXBM++=Z?&MO#X,F_P#U&86X
M<%(X_&F:M)/X\'X?V7*[\>.M:/BP.4;R7VBN^SF,$7M]L!F7\ SR];FDS!ZN
M($(&+*;Y!"MQ!X-\MM_2;Y6O]Y3QM]LCEHJGQU9L?^AY=H&>_JI7?%B:K E/
MM#.?W!3EB\8X>C1$1X3*QUY21R^H-37,S(;3\D*W$'A Y?1G&>XW:3S=PT?F
MW%:.H\;_ #.D']GM5EB\_P!(>?SC1J4:27GZ;PG9C=S3Q1%D'Z(,L>R"JA?[
MI)W0_(;3\BMU!X4.5$7RINDOGJ&M^+$%H*GQF<YYOD1:(?>TSG?'F/L5@2_G
MD;XI$IBM<APL-Q>F+QM8HB74/P32<-(F#3VC6Y@\,?)J#2ZWU,IXZN?^(YBT
M=1XM>?$XP;<Z2(<%%3^U[7J+9/S@-\\H8XK9\NY(#_@Q\'9<04NOX@Q< S.3
MXUOJ?D#R=IO<6.!WOY)W_&E*CM5XD^>E5[O,-0S\G%3L^+$%'$OYFF\R9*<K
MO<3F0"G^D1I>LC&ICJ @.A(]=N4O/Z K<T_*#E738&'+]KQ'680X_A8K05/.
M[G'5@B?,UWP/4V=S/B!JBV4WI[CIKB^M<T9>E./7B"1R/<KH!U]BS]0-*W]-
MD?)%'^BV:UQ^:EA_V%&ZOF!S K\?IM^N\@/;5S_[:C&4SA?\T<RDK<ES2*AN
M<S^Z9ER(_E<;@=:WD-MM=,,*:DI8QPQ1M]C0H_/=+Q5.VJJMK)2>MTTKO:\J
MW%\BSS@!!95977DZ^0?+_'I53:UFM=L>X#6^8 >P+7NC$GRCGN\Y)]I5+/=T
MB<W$+=EQ?C&2,<P>X3'J_OI>C:.'G5GT:#[D>H+\?K;+_@BU)^2W#^B8:H9)
M#TDE7"&)O0T+A-=4V;_XHA?R6Z(??*:K=IRNV&=BX37'-F_YQ6#\DJ1?O)A5
M,2JAC1U+A-.3!]=9)WR^I7A_]4 TIB57!O8%P&DY(_TG[P?>X5_]K2F)3 =@
M7 9RY/\ 3<.#?E+*&^^8:HBXA,8><YQ]YS#_ $:*N*_.@?\ IHF)7S0/4'PH
MF)7VB)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$
MHB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(KG_ (L5A_/+/_9U
MN95\_;?.W<KI=QP@J1)95,H'Q],@(E(<2AJ9.]"<N@>JOF]OA.Y6/8';=T!(
M'_QV?,KZG/C.YPL>YI99R 2/T>3Y]=I+[0'O<( =);V"E1](C8]QEU_,O@-*
ML=X2>6!.B:Z@?EH_F5Z-\:G-P>Z@LQ_F)1_7KNE^T%;T0^E:&"#_ /0^ZR_>
MOOTUYGPC\L^JINW]+%\RO4>-?FQUTEE_H9OGUVR_:$-XX?2L3 Q^7_[5O OR
M<E_5YGPB\MNJKN_])#\RO0>-KFJ.FBLI_FI_GUV ^T*[P0Y\=8$-_P!&[U#[
MU_59^Z'RX_OMW^'!\RO0>-SFD.F@LI_FZC]H7Z#[0ON_ 0$<;X$$/2'ZN7MR
M_"_P&J?NA\N/[[>/AP?,JO[[G-'_ )?9/Z.H_:%R_P#F&=W?_9G@/_J]?/\
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MR@Y61Z69?M6/Y!I]N*PY.=W."7Y3,MY(\E2\?%(5J/-\N\B0$3.]S^<EA'G
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+;H\GZ/Y?X8ZE_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img004_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img004_v1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ ,@"W P$1  (1 0,1 ?_$ *T   ,  P$!
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MHVGMQORW-(99*:J1))6.9:31 7;[K$X;+ZKUMO1[XF$TV;B^GW1I[H;<V_\
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L$,$(8(0P0A@A#!"&"$,$(8(0P0A@A#!"&"$,$(8(0P0A@A#!"&"$,$)__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
